EUVIMEDEUVIMED entdecken
Open Access

Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer

Dominik Enderlin, Maria Gloor, Uwe Bieri, Alekhya Mazumdar, Souzan Salemi, Niels Rupp, Holger Moch, Daniel Eberli, Cédric Poyet

Cancer Diagnosis & Prognosis · 01.11.2026 · 6 (6) · 947-960

DOI: 10.21873/cdp.10597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.11.2026. Verfasst von Dominik Enderlin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital of Zürich, Zürich, Switzerland. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aim: Reliable biomarkers to stratify prognosis in patients with muscle-invasive bladder cancer (MIBC) undergoing radical cystectomy (RC) remain limited. This study investigated whether the expression of the recently emerging proteins Nectin4 and interferon regulatory factor 6 (IRF6) is associated with pathological stage and oncological survival outcomes in patients undergoing RC for MIBC. Materials and Methods: Two tissue microarrays comprising of 163 patients treated with RC for MIBC were analyzed at the University Hospital of Zürich. Immunohistochemistry was performed for Nectin4 and IRF6, staining intensity was quantified using H-scores. Associations with pathological stage were assessed using logistic regression. Progression-free survival (PFS) and cancer-specific survival (CSS) were evaluated using Cox regression and Kaplan-Meier analysis. Results: Higher Nectin4 and cytoplasmic IRF6 expression were significantly associated with lower pathological T-stage and AJCC stage (p

Schlagwörter

Stichwörter der Autor:innen

IRF6Muscle-invasive bladder cancerNectin4pathological stageprogression free survival

Autor:innen und Institutionen

  • Department of Urology, University Hospital of Zürich, Zürich, Switzerland.
  • Institute of Pathology and Molecular Pathology, University Hospital of Zürich, Zürich, Switzerland.
  • Department of Urology, Stadtspital Triemli, Zürich, Switzerland.

Zitieren

APA

Enderlin, D., Gloor, M., Bieri, U., Mazumdar, A., Salemi, S., Rupp, N., Moch, H., Eberli, D., & Poyet, C. (2026). Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer. Cancer Diagnosis & Prognosis, 6(6), 947-960. https://doi.org/10.21873/cdp.10597

Vancouver

Enderlin D, Gloor M, Bieri U, Mazumdar A, Salemi S, Rupp N, et al. Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer. Cancer Diagnosis & Prognosis. 2026;6(6):947-960. doi:10.21873/cdp.10597

BibTeX
@article{Enderlin2026,
  author = {Enderlin, Dominik and Gloor, Maria and Bieri, Uwe and Mazumdar, Alekhya and Salemi, Souzan and Rupp, Niels and Moch, Holger and Eberli, Daniel and Poyet, Cédric},
  title = {Prognostic Impact of Nectin4 and IRF6 Expression in Patients Undergoing Radical Cystectomy for Muscle-Invasive Bladder Cancer},
  journal = {Cancer Diagnosis & Prognosis},
  year = {2026},
  volume = {6},
  number = {6},
  pages = {947--960},
  doi = {10.21873/cdp.10597}
}
Kostenlos starten →